Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Impact of Availability of Showerpatch for Patients With Intravenous Catheters [NA]
This clinical trial update notes that the study evaluating the impact of Showerpatch availability for patients with intravenous catheters ha…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis [Phase 1]
Phase 1 trial update showing safety and preliminary efficacy data for inhaled OligoG CF-5/20 in cystic fibrosis, sponsored by AlgiPharma.
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective
A completed clinical trial conducted by Imperial College London investigating infective pulmonary exacerbations in cystic fibrosis from an e…
-
FDA approval · 2016-03-18FDA Approved: ORKAMBI — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA approves a supplemental application for ORKAMBI (lumacaftor/ivacaftor) by Vertex Pharmaceuticals Incorporated.
-
CLINICAL_TRIALS research · 2016-03-09Clinical Trial Update: The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes [NA]
This clinical trial update describes evaluating a home oral glucose tolerance test kit to screen for cystic fibrosis-related diabetes in peo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis
An update on a clinical trial investigating impaired secretory IgA and mucosal immunity in cystic fibrosis. The status is unknown in the sni…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Exercise Training Study for Patients With Cystic Fibrosis [NA]
A clinical trial conducted by University of Pittsburgh evaluating exercise training in patients with Cystic Fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis [Phase 2]
Phase 2 study evaluating the efficacy and safety of Creon IR in pancreatic exocrine insufficiency due to cystic fibrosis has completed, with…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Near Patient Microbial Testing in Cystic Fibrosis [NA]
A clinical trial update about near-patient microbial testing in cystic fibrosis conducted by Papworth Hospital NHS Foundation Trust, with th…
-
CLINICAL_TRIALS research · 2016-02-15Clinical Trial Update: Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
This clinical trial update summarizes a mechanistic study in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) th…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis [Phase 2]
Phase 2 safety and tolerability study of inhaled Alpha-1 HC (alpha-1 proteinase inhibitor) in cystic fibrosis; results were posted in 2016.
-
CLINICAL_TRIALS withdrawal · 2016-02-08Clinical Trial Update: Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis
A clinical trial evaluating intermittent versus continuous infusion of meropenem in cystic fibrosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: MD2Me - Texting to Promote Chronic Disease Management [NA]
This clinical trial update notes the completion of the MD2Me texting program study aimed at improving chronic disease management in cystic f…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Phase II Study of Digitoxin to Treat Cystic Fibrosis [Phase 2]
Phase II trial update for digitoxin in cystic fibrosis has completed and results were posted in 2016.
-
CLINICAL_TRIALS research · 2016-01-15Clinical Trial Update: The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation
This clinical trial update investigates the prevalence and significance of gastro-oesophageal reflux in cystic fibrosis patients before and …
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Electro Flo 5000 and Vest Therapy [Phase 4]
Phase 4 clinical trial update from Stanford evaluating Electro Flo 5000 and Vest Therapy for cystic fibrosis has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and the G5 Flimm-Fighter in Patients With CF [NA]
This completed clinical trial compared the airway clearance efficacy of Electro Flo 5000 versus the G5 Flimm-Fighter in cystic fibrosis. Res…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients [Phase 1]
Phase 1 pharmacokinetic and safety study of IV gallium nitrate (Ganite) in cystic fibrosis patients has completed with results posted.
-
FDA approval · 2016-01-10FDA Approved: ACETYLCYSTEINE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Acetylcysteine from Fresenius Kabi USA, LLC, under an ANDA.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Contraceptive Hormones and Women With Cystic Fibrosis [Phase 1]
Phase 1 trial evaluating contraceptive hormones in women with cystic fibrosis. The study status is terminated.
-
FDA approval · 2016-01-06FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for TOBI PODHALER (tobramycin) from Viatris Specialty LLC.
-
FDA approval · 2015-12-28FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Cayston (aztreonam) filed by Gilead Sciences, Inc., resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Breath Analysis in in Adults With Cystic Fibrosis (CF) [NA]
A clinical trial update indicates completion of a study on breath analysis in adults with cystic fibrosis conducted by the University of Zur…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis [NA]
This is a completed clinical trial assessing whether adding positive expiratory pressure during inhalation of hypertonic saline benefits pat…
-
CLINICAL_TRIALS trial_result · 2015-11-27Clinical Trial Update: A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis [Phase 3]
A Phase 3 double-blind, randomized, cross-over trial comparing Creon N to Creon in subjects aged 12 or older with pancreatic exocrine insuff…